Desouza Errol B
SEC-identified person · CIK 1213895 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Alector, Inc. ALEC | Director | filed 2024 - 2026 |
| Royalty Pharma plc RPRX | Director | filed 2020 - 2025 |
| Cyclerion Therapeutics, Inc. [CYCN] | Director | filed 2021 - 2023 |
| Targacept INC TRGT | Director | filed 2006 - 2021 |
| Biodel Inc BIODEL | Director · CEO and President | filed 2010 - 2015 |
| Palatin Technologies INC PTN | Director | filed 2006 - 2010 |
| Idexx Laboratories INC /DE IDXX` | Director | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.